Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TEM
1401
CALL
Tempus AI
TEM
$8.32B
| $14.5M | ﹤0.01% |
180,000
-99,800
| -36% | -$6.99M |
|
1402
Medpace
MEDP
$16.3B
| $14.5M | ﹤0.01% |
28,219
+7,585
| +37% | +$3.31M |
|
1403
New Jersey Resources
NJR
$5.53B
| $14.5M | ﹤0.01% |
301,163
+63,679
| +27% | +$2.97M |
|
1404
Oshkosh
OSK
$9.47B
| $14.5M | ﹤0.01% |
111,764
+63,972
| +134% | +$8.49M |
|
1405
PagerDuty
PD
$856M
| $14.5M | ﹤0.01% |
875,971
-22,456
| -2% | -$357K |
|
1406
Lumen
LUMN
$6.09B
| $14.4M | ﹤0.01% |
2,360,882
-505,185
| -18% | -$2.42M |
|
1407
Tandem Diabetes Care
TNDM
$1.29B
| $14.4M | ﹤0.01% |
1,190,127
+623,055
| +110% | +$8.43M |
|
1408
CALL
Costco
COST
$421B
| $14.4M | ﹤0.01% |
15,600
-39,800
| -72% | -$38.1M |
|
1409
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.3B
| $14.4M | ﹤0.01% |
1,072,300
+856,400
| +397% | +$11.4M |
|
1410
Rhythm Pharmaceuticals
RYTM
$7.72B
| $14.4M | ﹤0.01% |
142,385
-208,813
| -59% | -$19.4M |
|
1411
iShares US Transportation ETF
IYT
$2.27B
| $14.3M | ﹤0.01% |
200,063
| – | – |
|
1412
PUT
iShares 3-7 Year Treasury Bond ETF
IEI
$17.7B
| $14.3M | ﹤0.01% |
120,000
+45,000
| +60% | +$5.35M |
|
1413
Ares Capital
ARCC
$14.1B
| $14.3M | ﹤0.01% |
701,459
+174,441
| +33% | +$3.88M |
|
1414
Universal Technical Institute
UTI
$1.53B
| $14.3M | ﹤0.01% |
439,222
+206,888
| +89% | +$6.08M |
|
1415
KB Home
KBH
$3.49B
| $14.3M | ﹤0.01% |
224,495
+17,594
| +9% | +$1.06M |
|
1416
CALL
Urban Outfitters
URBN
$6.65B
| $14.3M | ﹤0.01% |
200,000
-277,500
| -58% | -$20.4M |
|
1417
CALL
Avis
CAR
$4.89B
| $14.2M | ﹤0.01% |
+88,600
| New | +$14.9M |
|
1418
Vaxcyte
PCVX
$8.5B
| $14.2M | ﹤0.01% |
393,914
-44,495
| -10% | -$1.47M |
|
1419
CALL
Hims & Hers Health
HIMS
$6.87B
| $14.2M | ﹤0.01% |
250,000
-41,600
| -14% | -$2.13M |
|
1420
CALL
Occidental Petroleum
OXY
$55.7B
| $14.2M | ﹤0.01% |
300,000
-9,200
| -3% | -$416K |
|
1421
Federal Signal
FSS
$7.8B
| $14.2M | ﹤0.01% |
119,016
-21,617
| -15% | -$2.59M |
|
1422
Vanguard Morningstar Total Stock Market ETF
VTI
$680B
| $14.1M | ﹤0.01% |
42,982
-114
| -0.3% | -$36K |
|
1423
CALL
JD.com
JD
$44.3B
| $14.1M | ﹤0.01% |
402,900
-256,700
| -39% | -$8.36M |
|
1424
PUT
Bristol-Myers Squibb
BMY
$131B
| $14.1M | ﹤0.01% |
312,100
-1,768,000
| -85% | -$82.6M |
|
1425
Omega Healthcare
OHI
$14.8B
| $14.1M | ﹤0.01% |
333,359
-384,136
| -54% | -$15.5M |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.